Prostaglandin I2and thromboxane A2production in relation to α1and α2-adrenoreceptor activation in the normotensive and hypertensive rat
- 30 November 1988
- journal article
- research article
- Published by Wiley in Journal of Autonomic Pharmacology
- Vol. 8 (4) , 333-342
- https://doi.org/10.1111/j.1474-8673.1988.tb00577.x
Abstract
1. The perfused mesenteric arterial bed (MAB) from normotensive (WKY) and hypertensive (SHR) rats was used as a model to investigate the relationship between .alpha.1 and .alpha.2-adrenoreceptor activation and prostanoid release. 2. Prostaglandin I2 (PGI2) and small amounts of thromboxane A2 (TXA2) are released from this preparation and can be monitored in the perfusate under basal and stimulated conditions. 3. Noradrenaline (NA) caused a significant increase in the release of PGI2 from the MAB of both WKY and SHR. Both basal and NA-stimulated PGI2 release were lower in the SHR, whereas pressor responses to NA were higher. Noradrenaline caused a very small increase in TXA2 release in the WKY only and the basal release of the prostanoid was again lower in the SHR. 4. Prazosin, an .alpha.1-selective antagonist (10-10, 10-9, 10-8M) was more effective in blocking pressor responses to NA in the SHR than in the WKY, did not affect the NA-induced release of PGI2 in either group and abolished the small increase of TXA2 release in WKY. 5. Rauwolscine, an .alpha.2-selective antagonist (10-8, 10-7, 10-6 M) was more effective in reducing pressor responses to NA in the SHR than in the WKY. It abolished, from 10-7M upwards, the NA-induced release of PGI2 in the WKY and reduced it in the SHR. The NA-induced release of TXA2 was abolished in WKY. 6. The observed differences in the effects of rauwolscine and prazosin do not correlate with the effects of these antagonists on pressor responses since both reduce the latter but only rauwolscine abolishes the stimulated PGI2 release. 7. These results indicate that in the SHR, the mechanisms mediating the release of PGI2 from the MAB may be similar but not identical to those in the WKY. The observation that an increase in adrenergically induced pressor responses is not followed by an increase in PGI2 release, which is in fact reduced in the SHR, suggests a more complex regulation of this relationship which may have pathophysiological implications.This publication has 31 references indexed in Scilit:
- Role of cyclic GMP in the modulation by endothelium of the adrenolytic action of prazosin in the rat isolated aortaBritish Journal of Pharmacology, 1986
- Adrenergic stimulation of prostacyclin production in the rat tail artery. I. Response to agonists and antagonistsProstaglandins, Leukotrienes and Medicine, 1985
- Comparison of the ?-adrenoceptor antagonist profiles of idazoxan (RX 781094), yohimbine, rauwolscine and corynanthineNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1984
- Enhanced responsiveness of rat isolated aorta to clonidine after removal of the endothelial cellsBritish Journal of Pharmacology, 1984
- Release of prostaglandins by the mesenteric artery of the renovascular and spontaneously hypertensive ratCanadian Journal of Physiology and Pharmacology, 1984
- Non-competitive antagonism of the α-adrenoceptor-mediated fast component of contraction of rat aorta, by doxazosin and prazosinBritish Journal of Pharmacology, 1983
- Mechanical reduction in pressure and pulse pressure decreases the ability of hypertensive rat aortas to produce ‘PGI2-like’ activityProstaglandins and Medicine, 1981
- Thromboxane A2 in blood vessel walls and its physiological significance: Relevance to thrombosis and hypertensionProstaglandins and Medicine, 1980
- EVIDENCE FOR TWO DISTINCT TYPES OF POSTSYNAPTIC α‐ADRENOCEPTOR IN VASCULAR SMOOTH MUSCLE in vivoBritish Journal of Pharmacology, 1979
- Cardiovascular reactivity in the experimental hypertensive ratBritish Journal of Pharmacology, 1971